e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Immunopathological mechanisms of lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Study of the inflammatory phenotype of asthmatic patients with bronchiectasis
D. Ma (Barcelona, Spain), M. Cruz (Barcelona, Spain), C. Romero-Mesones (Barcelona, Spain), I. Ojanguren (Barcelona, Spain), D. Clofent (Barcelona, Spain), D. Varona (Barcelona, Spain), X. Muñoz (Barcelona, Spain)
Source:
International Congress 2019 – Immunopathological mechanisms of lung disease
Session:
Immunopathological mechanisms of lung disease
Session type:
Thematic Poster
Number:
4094
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Ma (Barcelona, Spain), M. Cruz (Barcelona, Spain), C. Romero-Mesones (Barcelona, Spain), I. Ojanguren (Barcelona, Spain), D. Clofent (Barcelona, Spain), D. Varona (Barcelona, Spain), X. Muñoz (Barcelona, Spain). Study of the inflammatory phenotype of asthmatic patients with bronchiectasis. 4094
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Autoreactivity and inflammatory phenotypes in patients with COPD and bronchial asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
Role of colonization on inflammation in COPD patients with bronchiectasis
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Role of neutrophils in airway inflammation in patients with pneumoconiosis and COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 322s
Year: 2004
Inflammatory cell counts in induced sputum from non-allergic asthmatics and COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 317s
Year: 2004
Smoking and airway inflammation in asymptomatic subjects and in patients with chronic airway disease
Source: Eur Respir J 2002; 20: Suppl. 38, 90s
Year: 2002
Small airways disease and peripheral eosinophilia predict airway hyperresponsiveness in Irish patients with suspected asthma
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Neutrophilic inflammation in severe asthmatics and COPD patients with the same severity of airway obstruction
Source: Eur Respir J 2002; 20: Suppl. 38, 505s
Year: 2002
Characteristics and mechanisms of bronchial hyper-responsiveness in symptomatic subjects with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 209s
Year: 2003
Association between eosinophilic airway inflammation and T-cells response in children with bronchial asthma
Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2010
Systemic and airway inflammation and the presence of emphysema in patients with COPD
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009
Evolution of cellular inflammatory pattern in induced sputum in patients with mild-moderate asthma for five years
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Inflammatory mediators in eosinophilic COPD phenotype and asthma with fixed airflow obstruction
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018
Heterogeneous response of airway eosinophilia to biologics in severe asthma patients
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021
Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017
Characteristics of eosinophilic and neutrophilic inflammation of bronchi of the bronchial asthma (BA) patients
Source: Eur Respir J 2001; 18: Suppl. 33, 32s
Year: 2001
Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011
Sputum induction elicits different peripheral airways responses in healthy subjects, asthma and allergic rhinitis patients
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Clinical response to mepolizumab in patients with severe eosinophilic asthma
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019
Bronchial reversibility and airway inflammation in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 436s
Year: 2003
Associations between inflammatory endotypes and phenotypes of obesity at young patients with bronchial asthma
Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept